Moa Life Plus Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
42
- Stock Symbol
-
142760
- Investments
-
1
- Share Price
-
$0.09
- (As of Thursday Closing)
Moa Life Plus General Information
Description
MOA Life Plus Co Ltd engages in the research and development of healthcare products.
Contact Information
Website
www.moalifeplus.comCorporate Office
- A-7, 767, Sinsu-ro
- Suji-gu
- Yongin, Gyeonggi 16827
- South Korea
Corporate Office
- A-7, 767, Sinsu-ro
- Suji-gu
- Yongin, Gyeonggi 16827
- South Korea
Moa Life Plus Timeline
Moa Life Plus Stock Performance
As of 12-Nov-2026, Moa Life Plus’s stock price is $0.09. Its current market cap is $1.85M with 21.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.09 | $0.07 | $0.06 - $2.57 | $1.85M | 21.1M | 1.64M | -$0.46 |
Moa Life Plus Financials Summary
As of 30-Jun-2026, Moa Life Plus has a trailing 12-month revenue of $7.21M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 14,750 | 47,892 | 12,471 | 108,012 |
| Revenue | 7,208 | 7,881 | 11,455 | 13,955 |
| EBITDA | (8,234) | (7,542) | (3,274) | 641 |
| Net Income | (9,421) | (9,171) | (5,126) | 6,126 |
| Total Assets | 21,044 | 29,588 | 42,261 | 38,080 |
| Total Debt | 3,799 | 4,643 | 10,415 | 5,216 |
Moa Life Plus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Moa Life Plus Patents
Moa Life Plus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250312395-A1 | Pharmaceutical composition for alleviationn, treatment, and prevention of sarcopenia containing microorganism transformed with cell surface display vector operably linked with gene encoding myostatin and activin a proteins as active ingredient | Pending | 05-Apr-2024 | ||
| WO-2022102894-A1 | Coronavirus vaccine using replication-deficient adenovirus that simultaneously expresses coronavirus spike protein and nucleocapsid protein | Inactive | 10-Nov-2020 | ||
| WO-2022103126-A1 | Coronavirus vaccine using replication-incompetent adenovirus that simultaneously expresses coronavirus spike protein and nucleocapsid protein | Inactive | 10-Nov-2020 | ||
| EP-3865578-A1 | Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof | Pending | 10-Oct-2018 | ||
| EP-3865578-A4 | Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof | Pending | 10-Oct-2018 | C12N15/67 |
Moa Life Plus Signals
Moa Life Plus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Moa Life Plus Investments (1)
Moa Life Plus’s most recent deal was a Joint Venture with Quintrigen. The deal was made on 28-May-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Quintrigen | 28-May-2019 | Joint Venture | Drug Discovery |
Moa Life Plus ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Moa Life Plus FAQs
-
When was Moa Life Plus founded?
Moa Life Plus was founded in 1999.
-
Where is Moa Life Plus headquartered?
Moa Life Plus is headquartered in Yongin, South Korea.
-
What is the size of Moa Life Plus?
Moa Life Plus has 42 total employees.
-
What industry is Moa Life Plus in?
Moa Life Plus’s primary industry is Pharmaceuticals.
-
Is Moa Life Plus a private or public company?
Moa Life Plus is a Public company.
-
What is Moa Life Plus’s stock symbol?
The ticker symbol for Moa Life Plus is 142760.
-
What is the current stock price of Moa Life Plus?
As of 12-Nov-2026 the stock price of Moa Life Plus is $0.09.
-
What is the current market cap of Moa Life Plus?
The current market capitalization of Moa Life Plus is $1.85M.
-
What is Moa Life Plus’s current revenue?
The trailing twelve month revenue for Moa Life Plus is $7.21M.
-
What is Moa Life Plus’s annual earnings per share (EPS)?
Moa Life Plus’s EPS for 12 months was -$0.46.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process